Abeona Therapeutics (ABEO) Interest & Investment Income (2011 - 2022)
Abeona Therapeutics (ABEO) recorded quarterly Interest & Investment Income of $30000.0 in Q2 2022, up 2900.0% quarter-over-quarter from $1000.0 in Q1 2022, and up 275.0% on a YoY basis from $8000.0 in Q2 2021.
Abeona Therapeutics (ABEO) Interest & Investment Income (2011 - 2022) Analysis & Trends
Abeona Therapeutics' Interest & Investment Income history runs 12 years deep, the most recent figure standing at $30000.0 for Q2 2022.
- In Q2 2022, Interest & Investment Income rose 275.0% year-over-year to $30000.0; the TTM figure through Jun 2022 stood at $77000.0 (down 80.8% YoY), while the FY2021 annual figure was $69000.0, down 94.7% from the prior year.
- Interest & Investment Income was $30000.0 for Q2 2022 at Abeona Therapeutics, up from $1000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $652000.0 in Q1 2020 to a low of $1000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $228611.1 across 5 years, with a median of $213500.0 in 2018.
- The sharpest annual moves came in 2018 and 2021: Interest & Investment Income surged 2280.95% in 2018, then slumped 97.7% in 2021.
- A 5-year view of Interest & Investment Income shows it stood at $533000.0 in 2018, then slipped by 28.71% to $380000.0 in 2019, then plunged by 89.47% to $40000.0 in 2020, then fell by 10.0% to $36000.0 in 2021, then retreated by 16.67% to $30000.0 in 2022.
- The last three Interest & Investment Income figures came in at $30000.0 (Q2 2022), $1000.0 (Q1 2022), and $36000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 597,319.59 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -14.79 Mn |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Dec 31, 2020 | 40,000.00 |
| Sep 30, 2020 | 338,000.00 |
| Jun 30, 2020 | 271,000.00 |
| Mar 31, 2020 | 652,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Sep 30, 2019 | 277,000.00 |
| Jun 30, 2019 | 52,000.00 |
| Mar 31, 2019 | 499,000.00 |
| Dec 31, 2018 | 533,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 317,000.00 |
| Mar 31, 2018 | 156,000.00 |
| Dec 31, 2017 | 301,000.00 |
| Sep 30, 2017 | 21,000.00 |